Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
about
In vitro correlates of HIV-2-mediated HIV-1 protectionChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strainsHIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulationFunctional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusionHIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptorsChronic alcohol abuse and HIV disease progression: studies with the non-human primate modelUnderstanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency virusesPersistent infection promotes cross-species transmissibility of mouse hepatitis virusInhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor useEffects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands.HIV-1 envelope determinants for cell tropism and chemokine receptor use.Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strainsModulation of gut-specific mechanisms by chronic δ(9)-tetrahydrocannabinol administration in male rhesus macaques infected with simian immunodeficiency virus: a systems biology analysis.Tracking members of the simian immunodeficiency virus deltaB670 quasispecies population in vivo at single-cell resolution.Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate.Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry.Simian immunodeficiency virus utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry.Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophagesN-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.Simian immunodeficiency viruses of diverse origin can use CXCR4 as a coreceptor for entry into human cellsCCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopesMutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolatesCharacteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strainsReceptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.Envelope is a major viral determinant of the distinct in vitro cellular transformation tropism of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.On the origin and evolution of the human immunodeficiency virus (HIV).Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques.In vitro and animal models of human immunodeficiency virus infection of the central nervous systemExpression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro.Prospects for an HIV vaccine: conventional approaches and DNA immunization.Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials.Toll-like receptor 3 signalling up-regulates expression of the HIV co-receptor G-protein coupled receptor 15 on human CD4+ T cells.Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesis
P2860
Q22254217-54DF5CFF-C3FD-4987-A33C-49390B5CC922Q24319950-F0BF5148-D72E-4BD2-8787-E96C13F9BB0EQ24676438-1694ECB4-45A5-4941-944C-E15495711213Q24678540-BB12C431-D109-44DB-B0CD-F70CA2C9F1C1Q24682714-327B2107-D884-4476-BADC-762EB99266C3Q26852432-0F0BC5BC-34D9-4E07-8A25-06F4E5E93740Q27021655-A7F7209F-C4B9-42E6-9212-335FC358BCF4Q27469338-5817D90A-3869-4D0A-8280-4773F73C6095Q28379182-B1627613-F952-4535-83FE-B4B192369784Q28379465-28C79241-4DAA-4E13-80B7-69015B867E9FQ29622903-68A0D3AD-99CD-438C-AA5C-04A6291B2D54Q33637941-F962E242-038A-46C5-A90D-6B2C2AD3CA0CQ33637946-973711CF-5246-46D7-B9FA-FFC29736F6FBQ33639712-B034BA35-83D9-44DC-AB36-55751131B5D0Q33647409-D6FCC7CF-A124-4FC0-97CB-75714A4FFBF1Q33713868-C30894BE-394A-45E7-950B-E2DB3634A04DQ33781894-7DA3CD85-311D-40F5-8C83-58BEBAEAD040Q33782925-BB0E3FDC-7937-491C-9F37-FD7793722BF7Q33783914-D9589972-2796-4925-8DD7-13811EA205A3Q33784897-7658D75F-D737-4E20-AF1C-DD3C25E9F510Q33787066-3739905E-BE7E-4C65-81E2-1F29AD1F66D8Q33787402-19AD21D8-5528-4757-8469-BEB18C69A4E6Q33804016-B8069535-9F1E-4534-AEC4-203EB9F97F27Q33806017-F39BF4DA-7D17-46E5-9904-10614D8B3BB7Q33807693-636B923C-F147-432D-8D34-8B03AFBADBF8Q33817249-AF7EDDFD-9E75-4869-AC23-15C47B8BDDFBQ33845764-F7C976EB-1F08-4844-BA8C-65B50D5EF1A6Q33851405-5B88B447-CF12-42E4-9BFD-397B4BD384D8Q33984358-05C74DF6-0688-479F-8388-B7EBCE5F1A02Q34010373-A8B97C6D-28A6-4567-BB35-97DA6DFF3245Q34142780-40242677-D360-4C32-BCBC-AED3EB3972C3Q34192490-E4D672F6-962C-4DF6-8072-27CE6BFE2472Q34276664-D98F028C-BCF4-43FA-92A1-78B02E32DA82Q34606565-B399D1C1-6A4D-4862-B055-1E825864BFBBQ34621972-CE3FEB31-18D8-413A-AED8-D47347199DEFQ35020221-5AA8D3BB-CCCA-4594-8C9B-252DDC71BD62Q35042496-3647F471-5D7B-4623-8F3E-540CD9AD2E52Q35049812-AF1F0592-AF67-4E5A-9CCF-645CCDFFF276Q35099526-83924997-DC33-41A9-8356-8C839FEB9CA7Q35103497-D18F5968-E616-4B1B-9E80-B81F06D4CC3D
P2860
Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Differential utilization of CC ...... immunodeficiency virus strains
@ast
Differential utilization of CC ...... immunodeficiency virus strains
@en
type
label
Differential utilization of CC ...... immunodeficiency virus strains
@ast
Differential utilization of CC ...... immunodeficiency virus strains
@en
prefLabel
Differential utilization of CC ...... immunodeficiency virus strains
@ast
Differential utilization of CC ...... immunodeficiency virus strains
@en
P2093
P2860
P356
P1476
Differential utilization of CC ...... immunodeficiency virus strains
@en
P2093
A L Edinger
B J Doranz
C C Broder
J E Clements
M Murphey-Corb
P2860
P304
P356
10.1073/PNAS.94.8.4005
P407
P50
P577
1997-04-01T00:00:00Z